Skip to main content
. 2017 Dec 20;162(2):499–508. doi: 10.1093/toxsci/kfx284

Table 8.

Summary of BSEP and MRP3 In Vitro Transport Inhibition and DILI Assessment for the Morgan et al. (2013) Dataset for Only BDDCS Classifiable Drugs

Criteria % of Drugs With DILI Predicted Correctly, PPV % of DILI Missing in the Prediction, FNR % of DILI Predicted Accurately, ACC (n = 99)
Css/IC50 BSEP Inhibition ≥ 0.1 93.5% 54.0% 63.6%
Above + Css/IC50 MRP 2, 3 or 4 Inhibition ≥ 0.1 90.0% 85.7% 44.4%
BDDCS Class 2 70.7% 15.9% 67.7%